UroGen Pharma Ltd. (URGN) › Total LiabilitiesUroGen Pharma Ltd. (URGN) — Total LiabilitiesAnnual figures by period end, from SEC filings.2016-12-31: $6.75M2017-12-31: $7.04M2018-12-31: $13.46M2019-12-31: $22.09M2020-12-31: $25.65M2021-12-31: $111.33M2022-12-31: $224.98M2023-12-31: $243.52M2024-12-31: $294.51M2025-12-31: $305.93M$305.93M2016-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$305.93M+3.9%2026-03-02Balance as of period end2024-12-31$294.51M+20.9%2026-03-02Balance as of period end2023-12-31$243.52M+8.2%2025-03-10Balance as of period end2022-12-31$224.98M+102.1%2024-03-14Balance as of period end2021-12-31$111.33M+334.0%2023-03-24Balance as of period end2020-12-31$25.65M+16.1%2022-03-21Balance as of period end2019-12-31$22.09M+64.0%2021-03-18Balance as of period end2018-12-31$13.46M+91.4%2020-03-02Balance as of period end2017-12-31$7.04M+4.2%2019-02-28Balance as of period end2016-12-31$6.75M—2018-03-15Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)